New diabetes clinical trial: Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects

Published on: July 28, 2023 at 11:00AM
Condition:   Type 2 Diabetes
Interventions:   Drug: HRS9531 injection;   Drug: HRS9531 injection Placebo
Sponsor:   Fujian Shengdi Pharmaceutical Co., Ltd.
Not yet recruiting
https://ift.tt/Sns2FMU